A consortium including Continental Grain, Bunge and Tekfen has pushed the crop nutrition product developer's total funding to more than $186m.

US-based crop nutrition technology developer Pivot Bio completed a $100m series C round yesterday featuring industrial conglomerate Tekfen and commodity trading firms Bunge and Continental Grain. Energy technology investment fund Breakthrough Energy Ventures (BEV) and Singaporean state-owned firm Temasek co-led the round, which included DCVC, Prelude Ventures, Spruce Capital Partners, Codon Capital, Pavilion Capital and…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.